SE8702907L - Stabil farmaceutisk preparation innehallande granulocytkoloniststimulerandefaktor och ett sett att producera densamma - Google Patents
Stabil farmaceutisk preparation innehallande granulocytkoloniststimulerandefaktor och ett sett att producera densammaInfo
- Publication number
- SE8702907L SE8702907L SE8702907A SE8702907A SE8702907L SE 8702907 L SE8702907 L SE 8702907L SE 8702907 A SE8702907 A SE 8702907A SE 8702907 A SE8702907 A SE 8702907A SE 8702907 L SE8702907 L SE 8702907L
- Authority
- SE
- Sweden
- Prior art keywords
- stimulating factor
- pharmaceutical preparation
- colonist
- granulocytic
- producing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/193—Colony stimulating factors [CSF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP16948886 | 1986-07-18 | ||
JP16948786 | 1986-07-18 | ||
JP16948986 | 1986-07-18 | ||
JP16948686 | 1986-07-18 |
Publications (3)
Publication Number | Publication Date |
---|---|
SE8702907D0 SE8702907D0 (sv) | 1987-07-17 |
SE8702907L true SE8702907L (sv) | 1988-01-19 |
SE503312C2 SE503312C2 (sv) | 1996-05-13 |
Family
ID=27474266
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE8702907A SE503312C2 (sv) | 1986-07-18 | 1987-07-17 | Farmaceutisk preparation innehållande en granulocytkolonistimulerande faktor G-CSF |
Country Status (24)
Country | Link |
---|---|
KR (1) | KR930004597B1 (sv) |
CN (1) | CN1033738C (sv) |
AT (1) | AT402259B (sv) |
AU (1) | AU611856B2 (sv) |
BE (1) | BE1000253A3 (sv) |
CA (1) | CA1297007C (sv) |
CH (1) | CH671157A5 (sv) |
DE (1) | DE3723781C2 (sv) |
DK (1) | DK171308B1 (sv) |
ES (1) | ES2010226A6 (sv) |
FR (1) | FR2601591B1 (sv) |
GB (1) | GB2193631B (sv) |
GR (1) | GR871067B (sv) |
HK (1) | HK64893A (sv) |
HU (1) | HU198627B (sv) |
IE (1) | IE60290B1 (sv) |
IL (1) | IL83220A (sv) |
IT (1) | IT1218927B (sv) |
NL (1) | NL192917C (sv) |
NO (1) | NO171828C (sv) |
PT (1) | PT85343B (sv) |
SE (1) | SE503312C2 (sv) |
SG (1) | SG64393G (sv) |
YU (1) | YU47543B (sv) |
Families Citing this family (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4929442A (en) * | 1986-09-26 | 1990-05-29 | Exovir, Inc. | Compositions suitable for human topical application including a growth factor and/or related materials |
US4847325A (en) * | 1988-01-20 | 1989-07-11 | Cetus Corporation | Conjugation of polymer to colony stimulating factor-1 |
NO179479C (no) * | 1988-03-11 | 1996-10-16 | Teikoku Seiyaku Kk | Fremgangsmåte for fremstilling av et intravaginalt farmasöytisk preparat |
US5981485A (en) | 1997-07-14 | 1999-11-09 | Genentech, Inc. | Human growth hormone aqueous formulation |
GB8824591D0 (en) * | 1988-10-20 | 1988-11-23 | Royal Free Hosp School Med | Fractionation process |
US5349052A (en) * | 1988-10-20 | 1994-09-20 | Royal Free Hospital School Of Medicine | Process for fractionating polyethylene glycol (PEG)-protein adducts and an adduct for PEG and granulocyte-macrophage colony stimulating factor |
US6132763A (en) * | 1988-10-20 | 2000-10-17 | Polymasc Pharmaceuticals Plc | Liposomes |
US5104651A (en) * | 1988-12-16 | 1992-04-14 | Amgen Inc. | Stabilized hydrophobic protein formulations of g-csf |
EP0459516A1 (en) * | 1990-06-01 | 1991-12-04 | Kirin-Amgen, Inc. | Oral dosage form of biologically active proteins |
JP3249147B2 (ja) * | 1990-06-01 | 2002-01-21 | キリン−アムジエン・インコーポレーテツド | 生理活性蛋白含有経口製剤 |
FR2686900B1 (fr) * | 1992-01-31 | 1995-07-21 | Rhone Poulenc Rorer Sa | Nouveaux polypeptides ayant une activite de stimulation des colonies de granulocytes, leur preparation et compositions pharmaceutiques les contenant. |
FR2686899B1 (fr) | 1992-01-31 | 1995-09-01 | Rhone Poulenc Rorer Sa | Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant. |
FR2693907B1 (fr) * | 1992-07-23 | 1994-09-02 | Rhone Poulenc Rorer Sa | Procédé d'administration de solutions de facteur de stimulation des colonies granulocytaires. |
EP0582932A1 (de) * | 1992-08-11 | 1994-02-16 | F. Hoffmann-La Roche Ag | Therapeutisches System zur parenteralen Verabreichung von hämatopoetischen Wachstumsfaktoren |
DE4242919A1 (de) * | 1992-12-18 | 1994-06-23 | Boehringer Mannheim Gmbh | Verfahren zur Herstellung von lagerstabilen wässrigen pharmazeutischen Zubereitungen von G-CSF |
DE4242863A1 (de) * | 1992-12-18 | 1994-06-23 | Boehringer Mannheim Gmbh | Stabile lyophilisierte pharmazeutische Zubereitungen von G-CSF |
US20030053982A1 (en) | 1994-09-26 | 2003-03-20 | Kinstler Olaf B. | N-terminally chemically modified protein compositions and methods |
US5824784A (en) | 1994-10-12 | 1998-10-20 | Amgen Inc. | N-terminally chemically modified protein compositions and methods |
WO1996024369A1 (en) * | 1995-02-06 | 1996-08-15 | Genetics Institute, Inc. | Formulations for il-12 |
TW434020B (en) * | 1995-03-15 | 2001-05-16 | Kirin Brewery | Methods for preventing adsorption of thrombopoietin (TPO), and stable top-containing compositions |
TW434021B (en) * | 1995-03-15 | 2001-05-16 | Kirin Brewery | Methods for preventing adsorption of thrombopoietin (TPO), and stable TPO-containing compositions |
GB9526733D0 (en) | 1995-12-30 | 1996-02-28 | Delta Biotechnology Ltd | Fusion proteins |
US20030190307A1 (en) | 1996-12-24 | 2003-10-09 | Biogen, Inc. | Stable liquid interferon formulations |
WO1999044630A1 (fr) * | 1998-03-06 | 1999-09-10 | Chugai Seiyaku Kabushiki Kaisha | Preparations exemptes de proteines |
US6979442B1 (en) * | 1998-08-17 | 2005-12-27 | Pfizer Inc. | Stabilized protein compositions |
EP1232753B1 (en) * | 1999-09-08 | 2008-03-19 | Chugai Seiyaku Kabushiki Kaisha | Stable protein solution filled in a container made from a hydrophobic resin and method of stabilizing the same |
AU2001236005A1 (en) * | 2000-02-29 | 2001-09-12 | Chugai Seiyaku Kabushiki Kaisha | Preparations stabilized over long time |
EP1129720B1 (en) * | 2000-02-29 | 2004-06-23 | Pfizer Products Inc. | Stabilized granulocyte colony stimulating factor |
EP1278544A4 (en) | 2000-04-12 | 2004-08-18 | Human Genome Sciences Inc | ALBUMIN FUSION PROTEINS |
US6946134B1 (en) | 2000-04-12 | 2005-09-20 | Human Genome Sciences, Inc. | Albumin fusion proteins |
AU8260701A (en) * | 2000-09-01 | 2002-03-13 | Chugai Pharmaceutical Co Ltd | Solution preparations stabilized over long time |
US8435939B2 (en) | 2000-09-05 | 2013-05-07 | Biokine Therapeutics Ltd. | Polypeptide anti-HIV agent containing the same |
US7507413B2 (en) | 2001-04-12 | 2009-03-24 | Human Genome Sciences, Inc. | Albumin fusion proteins |
EP2277910A1 (en) | 2001-12-21 | 2011-01-26 | Human Genome Sciences, Inc. | Albumin fusion proteins |
AU2003261723A1 (en) | 2002-08-27 | 2004-03-19 | Takeda Chemical Industries, Ltd. | Cxcr4 antagonist and use thereof |
JP4607010B2 (ja) | 2003-02-28 | 2011-01-05 | 中外製薬株式会社 | タンパク質含有安定化製剤 |
DE102006009437A1 (de) | 2006-03-01 | 2007-09-13 | Bioceuticals Arzneimittel Ag | G-CSF-Flüssigformulierung |
US8455450B2 (en) | 2006-12-21 | 2013-06-04 | Biokine Therapeutics Ltd. | Methods for obtaining a therapeutically effective amount of hematopoietic precursor cells and long term engraftment thereof |
US9155780B2 (en) | 2009-02-11 | 2015-10-13 | Yeda Research And Development Co. Ltd. | Short beta-defensin-derived peptides |
JP5657698B2 (ja) * | 2010-01-19 | 2015-01-21 | ハンミ サイエンス カンパニー リミテッドHanmi Scienceco.,Ltd. | 持続型顆粒球コロニー刺激因子結合体の液剤 |
EP2399572A1 (en) | 2010-06-22 | 2011-12-28 | Sandoz AG | Long-term storage of non-glycosylated recombinant human G-CSF |
AU2016291817A1 (en) | 2015-07-16 | 2018-02-22 | Biolinerx Ltd. | Compositions and methods for treating cancer |
CA3014530A1 (en) | 2016-02-23 | 2017-08-31 | Biolinerx Ltd. | Methods of treating acute myeloid leukemia |
WO2018138267A1 (en) | 2017-01-27 | 2018-08-02 | Cinfa Biotech S.L. | Method for determining the efficacy of a g-csf containing composition |
US20210196568A1 (en) * | 2018-05-21 | 2021-07-01 | Chugai Seiyaku Kabushiki Kaisha | Lyophilized formulation sealed in glass container |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2652636A1 (de) * | 1976-11-19 | 1978-05-24 | Hans Uwe Dr Rer Nat Wolf | Verfahren zur stabilisierung von proteinen und verwandten verbindungen waehrend ihrer reinigung, isolierung und lagerung |
AU523077B2 (en) * | 1978-03-20 | 1982-07-08 | Green Cross Corporation, The | Hgi glycoprotein |
DE3380726D1 (en) * | 1982-06-24 | 1989-11-23 | Japan Chem Res | Long-acting composition |
JPS60228422A (ja) * | 1984-04-26 | 1985-11-13 | Suntory Ltd | 安定化された生理活性物質製剤 |
JPS61227526A (ja) * | 1984-07-25 | 1986-10-09 | Chugai Pharmaceut Co Ltd | 新規なコロニー刺激因子 |
JPS6191131A (ja) * | 1984-10-09 | 1986-05-09 | Chugai Pharmaceut Co Ltd | 医薬品の吸着防止方法および組成物 |
DE3686794T2 (de) * | 1985-02-05 | 1993-03-04 | Cetus Oncology Corp | Reinigung des natuerlichen kolonie-stimulierenden faktors-1. |
US4810643A (en) * | 1985-08-23 | 1989-03-07 | Kirin- Amgen Inc. | Production of pluripotent granulocyte colony-stimulating factor |
JPH0618778B2 (ja) * | 1985-10-04 | 1994-03-16 | 中外製薬株式会社 | 白血球減少症治療剤 |
-
1987
- 1987-07-08 GR GR871067A patent/GR871067B/el unknown
- 1987-07-10 IT IT67594/87A patent/IT1218927B/it active
- 1987-07-13 NL NL8701640A patent/NL192917C/nl not_active IP Right Cessation
- 1987-07-14 AT AT0177587A patent/AT402259B/de not_active IP Right Cessation
- 1987-07-15 BE BE8700787A patent/BE1000253A3/fr not_active IP Right Cessation
- 1987-07-15 CA CA000542239A patent/CA1297007C/en not_active Expired - Lifetime
- 1987-07-15 DK DK368387A patent/DK171308B1/da not_active IP Right Cessation
- 1987-07-15 AU AU75665/87A patent/AU611856B2/en not_active Expired
- 1987-07-16 PT PT85343A patent/PT85343B/pt unknown
- 1987-07-16 NO NO872966A patent/NO171828C/no not_active IP Right Cessation
- 1987-07-16 CH CH2727/87A patent/CH671157A5/de not_active IP Right Cessation
- 1987-07-17 SE SE8702907A patent/SE503312C2/sv not_active IP Right Cessation
- 1987-07-17 IE IE193387A patent/IE60290B1/en not_active IP Right Cessation
- 1987-07-17 IL IL83220A patent/IL83220A/xx not_active IP Right Cessation
- 1987-07-17 YU YU134287A patent/YU47543B/sh unknown
- 1987-07-17 HU HU873268A patent/HU198627B/hu unknown
- 1987-07-17 ES ES8702106A patent/ES2010226A6/es not_active Expired
- 1987-07-17 DE DE3723781A patent/DE3723781C2/de not_active Expired - Lifetime
- 1987-07-17 FR FR878710156A patent/FR2601591B1/fr not_active Expired - Lifetime
- 1987-07-17 GB GB8716904A patent/GB2193631B/en not_active Expired - Lifetime
- 1987-07-18 CN CN87104963A patent/CN1033738C/zh not_active Expired - Lifetime
- 1987-07-18 KR KR1019870007804A patent/KR930004597B1/ko not_active IP Right Cessation
-
1993
- 1993-05-18 SG SG64393A patent/SG64393G/en unknown
- 1993-07-08 HK HK648/93A patent/HK64893A/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE8702907L (sv) | Stabil farmaceutisk preparation innehallande granulocytkoloniststimulerandefaktor och ett sett att producera densamma | |
BG60102B2 (bg) | Метод за получаване на 5-флуор-2(((4-циклопропил- метокси-2-пиридинил)метил)тионил)-1н-бензимидазол | |
SE8300623D0 (sv) | Farmaceutisk komposition innehallande stabil mikrokristallin cis-platina(ii)-diammindiklorid (cisplatin) | |
SE8406081D0 (sv) | Method and composition for the preparation of controlled long-acting pharmaceuticals for oral administration | |
LU88306I2 (fr) | Felodipine (Plendil) | |
LV10954A (lv) | Benzimidazola atvasinajumi to iegusanas panemiens un tos saturosa farmaceitiska kompozicija | |
FI921030A (fi) | Cykliska ureaderivat, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning | |
ATE26115T1 (de) | Substituierte 8-phenylxanthine. | |
SE8303013L (sv) | B-gamma-dihydropolyprenylalkoholderivat och farmaceutisk komposition innehallande en polyprenylforening | |
JPS542316A (en) | Solid pharmaceutical composition containing nifedipene | |
FR2442836A1 (fr) | 1,2,4,5-tetra-alkyl-4-arylpiperidines, leur preparation et leur utilisation therapeutique | |
SE8704952D0 (sv) | Farmaceutisk komposition | |
ES2037709T3 (es) | Derivados heterociclicos de seis miembros de n,n'-diacilhidrazinas n'-sustituidas. | |
BG78461A (bg) | Фунгициден състав и метод за борба с фунги | |
OA07539A (fr) | Nouveaux dérivés d'acides phényl aliphatiques, leur préparation, leur application comme médicaments, et les compositions les renfermant. | |
FR2428629A1 (fr) | Nouveaux composes bis(aryloxycarboxyliques), leur preparation et leur utilisation en therapeutique | |
SE8700555L (sv) | Purinderivat, deras framstellning och lekemedel innehallande dessa | |
ES8102096A1 (es) | Procedimiento para la obtencion de derivados de 3,4,5-trihi-droxipiperidina | |
DK527186D0 (da) | Bronchodilaterende farmaceutisk praeparat | |
BG94824A (bg) | Таблетка, съдържаща натриев 2-меркаптоетансулфонат (месна), като активно вещество и метод за получаването й | |
IL82925A0 (en) | Tetrahydrobenzothiazoles,their preparation and pharmaceutical compositions containing them | |
BR7905038A (pt) | Composicoes inseticidas,seu uso e preparacao do composto ativo | |
ATE18761T1 (de) | Carbamoyloxybenzhydrol-derivate, ihre herstellung und ihre pharmazeutische zusammensetzungen. | |
SE8704240D0 (sv) | Analgesic preparations | |
MA20974A1 (fr) | Derives propargyloxybenzenes, leur preparation et compositions fongicides les contenant |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NUG | Patent has lapsed |